Children’s Hospital Los Angeles Researchers Probe Immune Microenvironment to Prevent Pediatric Liver Transplant Rejection

Children with liver transplants must take immunosuppressant medications for life. To maintain tolerance of the transplanted liver, doctors treat transplant rejection and conduct ongoing maintenance immunosuppression by increasing dosages of medication enough to counteract rejection. CHLA researchers are developing an imaging panel that identifies the cell types implicated in transplant rejection.